Home > Insider Trading > Filing (0001171843-15-000598)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1466630	A Timothy Dick	1925 West Field Court Suite 300 Lake Forest IL 60045	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-01	61,111	$2.61	246,311	No	4	M	Direct
Common Stock	Disposition	2015-02-01	30,750	$42.19	215,561	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-02-01	61,111	$0.00	61,111	$2.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2015-05-21	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2014.
Upon execution of transactions disclosed on this Form 4, all securities subject to the 10b5-1 trading plan have been transacted and the plan has expired pursuant to its terms.
All proceeds from the sale were used to cover exercise price and taxes due upon exercise of options.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $41.81 to $42.93 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
Amount of Shares Beneficially Owned Following Reported Transaction includes 45,789 unvested shares subject to a restricted stock awards and 169,772 shares owned outright.
The option vested in three annual installments with 122,222 options vesting on each of May 21, 2011 and May 21, 2012, and 122,223 options vesting on May 21, 2013.
Exercise of stock options that were approaching their 5-year expiration date.
There was no consideration given in exchange for the security.